Skip to content

Pain Assessment by Pupil Dilation Reflex (PDR) and Pupillary Pain Index (PPI) in Response to Noxious Stimulation in Anesthetized Adults

Pain Assessment by Pupil Dilation Reflex (PDR) and Pupillary Pain Index (PPI) in Response to Noxious Stimulation in Anesthetized Adults

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03140241
Enrollment
34
Registered
2017-05-04
Start date
2017-05-07
Completion date
2017-07-20
Last updated
2018-05-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Monitoring, Intraoperative, Nociceptive Pain

Brief summary

After conduction a pilot study, pupillary dilation reflex (PDR) is measured in response to nociceptive stimulation perioperatively.

Detailed description

An infrared camera of the video pupillometer measures the pupillary dilation reflex (PDR) in response to incremental nociceptive stimuli. The PDR is a robust reflex, even in patients under general anesthesia, and may provide a potential evaluation of the autonomous nociceptive circuit. American Society of Anesthesiologists (ASA) classification I or II patients undergoing elective surgery under general anesthesia are recruited. Enrolled patients perioperative undergo PDR measurement at 2 different standardized times (before and after opioid administration) generated by an inbuilt pupillary pain index (PPI) protocol. PPI, as a surrogate for nociception includes noxious stimulations from 10 up to 60 milli ampere (mA) until pupil dilation is larger than 13% from baseline diameter. Therefore, no inappropriate high stimulation is executed.

Interventions

PDR measurement at two standardized times perioperatively: 1. : anesthetized subject by propofol sedation until sedation depth monitor NeuroSense® (NeuroWave Systems Inc, Cleveland, OH) between 40-50 2. : administration of remifentanil via effect site target concentration (Minto-model) at 5 ng/ml, in the absence of adjustments in sedation depth

Sponsors

University Hospital, Antwerp
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DIAGNOSTIC
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* Scheduled abdominal or gynecological surgery * ASA I-II

Exclusion criteria

* History of eye deformity, invasive ophthalmologic surgery * Known cranial nerve(s) deficit * Infection of the eye * Predicted difficult airway management (DAF Guidelines) * Chronic opioid use (\>3 months) * Ongoing treatment with beta-blockers, dopamine antagonists, topical atropine * Preoperatively administrated benzodiazepins or antiemetics

Design outcomes

Primary

MeasureTime frameDescription
Stimulation IntensityDuring perioperative periodNecessary stimulation intensity to dilate the pupil more than 13%

Secondary

MeasureTime frameDescription
Pupillary Pain Index scoreDuring perioperative periodDevice specific PPI score defined in accordance to stimulation intensity necessary for pupil dilation more than 13%
Systolic blood pressureDuring PDR measurementsHypertension as a common used parameter for perioperative nociceptive assessment
Heart rateDuring PDR measurementsTachycardia as a common used parameter for perioperative nociceptive assessment

Countries

Belgium

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026